A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression
Clinical trial NCT00482261 · COMPLETED
Trial details
- NCT number
- NCT00482261
- Sponsor
- Peter MacCallum Cancer Centre, Australia
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2010-08-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.